NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001300

Registered date:11/08/2008

The effects of angiotensin II receptor blockers (ARBs) on oxidative stress and atherosclerosis in patients with hypertension.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedPatients with hypertension
Date of first enrollment2005/11/01
Target sample size120
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)ARBs (select one from the following agents) Olemesartan 10-40mg/day Losaratan 25-100mg/day Telmisaratn 20-80mg/day The assessement will be done at baseline, 3, 6 and 12 months after the treatment. Calcium channel antagonist Nefidipine (Adalat-CR) 20-40mg/day The assessement will be done at baseline, 3, 6 and 12 months after the treatment.

Outcome(s)

Primary OutcomeThe effects of ARBs on the parameters listed below at baseline, 3, 6, and 12 months after the administrations. (1) Blood samples (lipid profiles, glucose tolerance, high-sensitive CRP, BNP, etc.) (2) Oxidative stress marker (8-OHdG, 8-isoprostane, etc.) (3) Electrocardiography (4) Echocardiography (5) Carotid ultrasonography (6) Pulse wave velocity
Secondary OutcomeEvaluation of newly developed oxidative stress marker, such as oxidative LDL (negatively charged LDL) and glutathionylated protein

Key inclusion & exclusion criteria

Age minimum40years-old
Age maximum85years-old
GenderMale and Female
Include criteria
Exclude criteriaSevere liver, renal or respiratory diseases Active infectious and inflammatory diseases Acute phase of heart failure Unstable angina Secondary hypertension

Related Information

Contact

public contact
Name Satoshi Ikeda
Address 1-7-1 Sakamoto, Nagasaki Japan
Telephone 095-819-7273
E-mail sikeda@nagasaki-u.ac.jp
Affiliation Nagasaki University School of Medicine Second Department of Internal Medicine
scientific contact
Name Satoshi Ikeda
Address 1-7-1 Sakamoto, Nagasaki Japan
Telephone 095-819-7273
E-mail
Affiliation Nagasaki University School of Medicine Second Department of Internal Medicine